Santé log

Pennsylvania Perio & Implants Announces Strengthened Commitment to Evidence-Based Periodontal and Dental Implant Evaluation in Pennsylvania

Pennsylvania Perio & Implants today announced the reinforcement of its evidence-based framework for periodontal evaluation and dental implant assessment across its York and Hanover locations. Under ...
Santé log

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

The JS001sc-002-III-NSCLC Study is a multi-center, open-label, randomized Phase 3 clinical study led by the principal investigator Professor Lin WU from Hunan Cancer Hospital. JS001sc-002-III-NSCLC is ...
Santé log

Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue

For the quarter ending December 31, 2025, management expects gross revenue of more than US$30.0 million from sales of Ryoncil ® (remestemcel-L-rknd). This represents more than 37% increase on the ...
Santé log

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction ...

The world-renowned, peer-reviewed, open-access Nature journal, Signal Transduction and Targeted Therapy, publishes original research on cutting-edge experimental and clinical advances on ...
Santé log

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

Lotte New York Palace To schedule a 1x1 meeting with the Company, please contact your Piper Sandler institutional sales representative. About Eton Pharmaceuticals Eton is an innovative pharmaceutical ...
Santé log

ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

The webcast of the fireside chat discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days ...
Santé log

Informations relatives aux activités de stabilisation menées dans le cadre de sa récente offre au public

Daix (France), New York City (New York, États-Unis), le 24 novembre 2025 - Publication d'informations relatives aux activités de stabilisation menées dans le cadre de la récente offre au public d'Inve ...
Santé log

Rani Therapeutics to Participate in the Evercore Healthcare Conference

8th Annual Evercore Healthcare Conference Date: Wednesday, December 3, 2025 at 8:45 am E.T. Location: Coral Gables, FL Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, ...
Santé log

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

One-time dose of Itvisma replaces SMN1 gene, potentially reducing the need for chronic SMA treatment ...
Santé log

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at https://ir.aurabiosciences.com/events-and ...
Santé log

Tarsus to Participate in Upcoming Investor Conference

IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the BTIG 5 th Annual Ophthalmology ...
Santé log

Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting

The AES meeting is a cornerstone for the epilepsy community, bringing together science, clinical innovation, and patient advocacy,” said Steven Petrou, chief scientific officer and co-founder of ...